Main menu

A nanopore sequencing-based pharmacogenomic panel to personalise tuberculosis drug dosing


The primary aim of this study was to evaluate a targeted panel based on Oxford Nanopore sequencing to understand pharmacogenomic effects on dosing for tuberculosis (TB) drugs. Standardised dosing often results in variability in drug plasma levels, leading to adverse drug reactions, delayed treatment response, or relapse. The researchers sought to create a pharmacogenomic assay that would predict drug metabolism by detecting mutations in key genes involved in TB drug metabolism, including those that impact isoniazid (INH), rifampin (RIF), linezolid (LZD), and bedaquiline (BDQ).

The study utilized the Oxford Nanopore MinION sequencer to perform pharmacogenomic analysis. The nanopore sequencing panel targeted 15 SNPs across five genes (NAT2, CYP2E1, SLCO1B1, AADAC, and CYP3A5), which affect the metabolism of these TB drugs. This assay was investigated on samples from the 1000 Genomes Project and then applied to 100 individuals from South Africa affected with TB.

Key findings revealed that 33% of the patients were slow acetylators of INH, 47% were intermediate, and 20% were rapid acetylators. INH clearance was significantly higher among rapid acetylators compared to slow acetylators, showing a 3.8-fold increase. For RIF, the study found a 17.3% lower clearance in patients with the AADAC rs1803155 mutation. This approach using Nanopore sequencing demonstrated that it could effectively detect genetic variations impacting TB drug metabolism, with potential for providing an affordable and scalable solution for personalising TB treatment dosing in diverse populations.

Authors: Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E. Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert J Wilkinson, Jason R. Andrews

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag